• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxamides

N-Ethyl-4-piperidinecarboxamide hydrochloride: A Comprehensive Overview

N-Ethyl-4-piperidinecarboxamide hydrochloride is a synthesized compound that has garnered significant attention in the field of biopharmaceuticals. This compound, also referred to as 1-(ethyl)-4-piperidinecarboxamide hydrochloride, belongs to a class of compounds known for their potential applications in drug delivery systems and as intermediates in pharmaceutical synthesis. Its structure comprises a piperidine ring substituted with an ethyl group at the 4-position and a carboxamide moiety, along with a hydrochloride counterion.

The compound's unique properties make it a subject of interest for researchers exploring novel drug delivery mechanisms. The piperidine ring, a six-membered saturated cyclic amine, provides the molecule with rigidity and structural integrity, while the ethyl substitution enhances its lipophilic characteristics. The carboxamide group, on the other hand, offers versatility in terms of potential functionalizations, making it a valuable component in pharmaceutical intermediates.

In recent years, there has been a growing focus on compounds likeN-Ethyl-4-piperidinecarboxamide hydrochloride due to their potential applications in central nervous system (CNS) drug delivery. Researchers have explored the use of such compounds as carriers for delivering therapeutic agents across the blood-brain barrier, a critical challenge in neuropharmacology. The molecule's ability to form stable complexes with drugs and its favorable pharmacokinetic profile make it an attractive candidate for controlled drug delivery systems.

One of the key advantages ofN-Ethyl-4-piperidinecarboxamide hydrochloride lies in its ability to act as a molecular transporter. This function is facilitated by the presence of both hydrophilic and lipophilic moieties within the molecule. The piperidine ring contributes to the compound's hydrophilicity, while the ethyl group enhances its lipophilicity, creating a balance that enables efficient drug solubilization and delivery.

Recent studies have also investigated the role of this compound in cancer therapy. Its ability to form stable complexes with anti-cancer drugs has led to explorations in targeted drug delivery systems. The hydrochloride salt form ensures improved solubility, which is crucial for systemic administration and bioavailability optimization.

Furthermore, the compound's role in biological imaging has been explored. Its ability to chelate metal ions and form stable coordination complexes makes it a potential candidate for contrast agent development in magnetic resonance imaging (MRI). This application underscores its versatility across multiple therapeutic and diagnostic domains.

The synthesis ofN-Ethyl-4-piperidinecarboxamide hydrochloride is well-documented, involving multi-step organic chemistry procedures. The key steps include the formation of the piperidine ring, ethylation at the 4-position, and subsequent functionalization with the carboxamide group. Optimization studies have focused on improving reaction yields and purity, ensuring the compound's suitability for large-scale production.

Quality control is a critical aspect of working with this compound. Analytical techniques such as high-performance liquid chromatography (HPLC) andnuclear magnetic resonance (NMR) are employed to ensure consistency in purity and structural integrity. These measures are essential for maintaining the compound's efficacy and safety profile.

In conclusion, N-Ethyl-4-piperidinecarboxamide hydrochloride stands out as a versatile compound with wide-ranging applications in the biomedical field. Its role in drug delivery, pharmaceutical synthesis, and biological imaging positions it as an important tool for researchers and clinicians alike. As research continues to uncover new potentials, this compound is poised to play a significant role in advancing biomedical innovations.

• 179683-97-7(2-Piperidinone,3,5-dimethyl-)
• 3768-43-2(3-Methylpiperidin-2-one)
• 189763-34-6(6-oxopiperidine-3-carboxamide)
• 29553-51-3(3-Methylpiperidine-2,6-dione)
• 39711-79-0(N-Ethyl-2-isopropyl-5-methylcyclohexanecarboxamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)